Adma Biologics | ADMA - Revenu Net

Prix De L'Action
9.70
Variation Quotidienne
-0.24 -2.41%
Mensuellement
-38.10%
Annuel
-50.00%
Q2 Prévisions
9.44




Revenu Net Changement Date
Adma Biologics USD 49.38M 12.95M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Novavax USD 17.53M 219.91M 2025-12
Omeros USD -32.23M 23.81M 2024-09
Takeda JPY 103.64B 115.44B 2025-12